RM Magazine - autumn 2012 - The Royal Marsden

Hospital news
Community Services
on way to achieve a
UNICEF accreditation
The dedication of Community
Services staff to improve
support for women
breastfeeding in Sutton
and Merton has been
recognised with an
international accreditation.
After months of hard work,
the health visiting service
has passed the prestigious
Stage 2 assessment in
working towards the UNICEF
Baby Friendly Initiative
with flying colours. Passing
Stage 2 confirms that
members of the health visiting
teams have the knowledge
and skills to support women
to breastfeed successfully.
Anne Reilly, Midwife and
Infant Feeding Co-ordinator
for Sutton and Merton
Community Services, said:
“We decided to work with
the UNICEF Baby Friendly
Initiative as a way of helping
to increase breastfeeding
rates and improve care,
support and information
for all mothers in Sutton
and Merton.
“Everyone is working really
hard to improve the support
and information local women
receive about infant feeding,
and passing this assessment
to such a high standard is a
testament to the dedication
shown by all our teams.
Our efforts have paid off
and the service is something
to be very proud of.”
The team is now preparing
for the final Stage 3, and
passing this will mean the
service is awarded the
international Baby Friendly
accreditation.
Royal marsden
consultant has been
awarded the title of
Professor by The institute
of Cancer Research (iCR).
The research of Chris nutting,
Consultant Clinical Oncologist
in the Head and neck Unit, has
been honoured by the iCR
Credentials Committee, which
conferred the title of Professor
after considerable deliberation
and extensive soundings from
international experts.
The committee also honoured
the work of the iCR’s Kevin
Harrington, an Honorary
Consultant at The Royal
marsden, awarding him the
title of Professor.
Professor nutting said:
“This is a real honour – i am
so delighted. The aim of my
research work, including the
Professor Chris Nutting
Research work recognised
CoNsultaNts hoNoured
with ProfessorshiPs
A
PaRSPORT trial, is to improve
cure rates for patients with
head and neck cancer and
preserve their quality of life,
which is extremely important.
i am pleased that this has
been recognised.”
Professor Harrington, Team
Leader of the iCR’s Targeted
Therapy Team and Consultant
Oncologist, said: “i am delighted
that the iCR Credentials
Committee has recognised my
work in head and neck cancer
drug development. The trials
show true joint working between
The Royal marsden and the
iCR, and i am extremely excited
about the current progress of the
new drug RT3D, also known as
Reolysin, and the impressive
response rates in patients.”
Professor martin gore,
The Royal marsden’s medical
Professor
Kevin
harrington
Director, said the honours
recognise the contributions
of both professors to the joint
working of both institutions.
He said: “Professors nutting
and Harrington have both
been totally committed to
trying to improve outcomes
for patients with head and
neck cancer. Through their
work, they have made a
real difference.”
06 RM magazine